查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1768823

全球连网药物传输设备市场

Connected Drug Delivery Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 172 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球连网药物输送设备市场规模将达到 255 亿美元

全球连网药物输送设备市场规模预计在2024年为79亿美元，预计到2030年将达到255亿美元，2024年至2030年期间的复合年增长率为21.5%。独立组件和软体是本报告分析的细分市场之一，预计其复合年增长率为20.2%，到分析期结束时规模将达到148亿美元。集成设备细分市场在分析期间内的复合年增长率预计为23.4%。

美国市场预计将达到 21 亿美元，中国市场复合年增长率将达到 20.4%

美国连网药物输送设备市场规模预计在2024年达到21亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到39亿美元，在2024-2030年的分析期间内，复合年增长率为20.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为19.3%和18.4%。在欧洲，预计德国市场的复合年增长率约为14.7%。

全球连网药物输送设备市场－主要趋势与驱动因素摘要

什么是连网药物传输设备？为什么它们会改变医疗保健？

连网药物输送设备是指配备感测器和连接功能的医疗设备，用于监测和管理药物的给药。这些设备包括智慧吸入器、胰岛素笔、穿戴式註射器、自动注射器等，并即时向医疗服务提供者传输使用数据，从而深入了解患者的依从性和治疗效果。连网药物输送设备可以提高患者依从性，提供个人化的用药指导，并实现远端患者监控。透过促进患者与医疗服务提供者之间的无缝沟通，这些设备正在改变医疗服务方式，确保患者获得最有效、最个人化的照护。

连网药物输送设备的重要性在于它们能够提高患者参与度和对处方方案的依从性，这对于管理糖尿病、气喘和类风湿性关节炎等慢性疾病至关重要。这些设备收集的数据为医疗保健提供者提供了有关治疗模式和患者行为的可行见解，从而能够在出现依从性问题时进行主动干预。此外，连网型设备提供的即时回馈使患者用药管理更加有效，降低了漏服和潜在併发症的风险。随着医疗保健系统越来越注重以患者为中心、数据驱动的护理，连网药物输送设备在改善治疗效果方面发挥关键作用。

科技进步如何改善连网药物传输装置？

技术进步正在迅速提升连网药物传输设备的功能和应用，使其更加精准、患者友善且用途广泛。蓝牙、Wi-Fi 和近距离场通讯(NFC) 技术的集成，实现了资料从装置到行动应用程式和云端平台的无缝传输，使医疗专业人员能够即时分析和存取资料。人工智慧和机器学习演算法也正在改变连网药物输送设备，使其能够制定个人化的用药方案，并根据患者行为预测依从性模式，从而改善整体治疗效果。

穿戴式科技的发展催生了更舒适、更隐密的设备，例如智慧胰岛素帮浦和穿戴式註射器，使患者能够在最大程度上减少服药对日常生活的干扰。此外，与行动应用程式的整合使患者能够接收提醒、剂量追踪和教育资源，从而鼓励患者坚持服药，并帮助患者主动管理自身病情。更长的电池寿命和更小的尺寸使这些设备更加便携易用，满足了活跃且移动性强的患者的需求。这些技术进步使联网给药设备成为现代医疗保健的重要组成部分，提高了患者的依从性、便利性和治疗成功率。

连网药物输送设备在患者照护上的主要应用是什么？

连网药物传输设备正广泛应用于慢性病管理领域，在这些领域，持续的服药顺从性至关重要。在糖尿病管理中，智慧胰岛素笔和连续血糖监测仪 (CGM) 使患者能够精准管理和追踪胰岛素剂量，提供数据支援个人化给药，并降低併发症风险。在气喘和慢性阻塞性肺病(COPD) 等呼吸系统疾病中，连网吸入器可提供吸入器使用情况的提醒和回馈，帮助患者遵守处方用药方案，并允许医护人员远端监控病情控制情况。

在肿瘤学领域，穿戴式註射器可以控制化疗药物的输送，减少患者频繁就诊的需要，并允许患者在家中管理治疗。在类风湿性关节炎的治疗中，连网自动注射器正被用于确保患者按处方接受药物，并提供数据供医护人员优化治疗方案。在临床试验中，连网药物传输设备透过收集精确的剂量资讯来提高数据准确性，减少对患者自我报告的依赖，并提高试验的完整性。这些应用凸显了连网药物输送设备在支援从疾病管理到临床研究等患者照护各个方面的多功能性。

哪些因素推动了连网药物输送设备市场的成长？

连网药物输送设备市场的成长受到多种因素的推动，包括慢性病发病率的上升、连线健诊技术的进步以及对患者依从性的日益重视。随着糖尿病、气喘和心血管疾病等慢性病的发生率不断上升，连网药物输送设备的需求也随之增加，因为它们在提高依从性和确保有效治疗效果方面发挥着重要作用。人工智慧、行动应用整合和即时数据分析等技术进步增强了这些设备的功能，使其更易于使用，并能够有效地进行远端患者护理管理。

远距远端医疗和远端患者监护日益普及，使医疗服务提供者能够追踪患者服药依从性并在必要时进行干预，从而减少就诊次数并提高病人参与。此外，对个人化医疗的日益关注也增加了对提供可客製化给药方案和即时监控设备的需求，这与量身定制治疗方案的趋势一致。此外，製药公司和医疗服务提供者意识到连网药物输送设备在临床试验中的优势，这可以提高数据准确性和患者依从性。这些因素共同推动了连网药物输送设备市场的扩张，在日益数位化的医疗环境中，该市场在改善医疗服务和患者预后方面发挥着重要作用。

部分

产品（独立组件和软体、整合设备）；给药途径（肠胃外、吸入）；应用（糖尿病管理应用、慢性阻塞性肺病应用、气喘应用、其他应用）

受访公司范例

  • Adherium Limited
  • Aterica
  • Biocorp
  • FindAir
  • Merck KGaA
  • Phillips Medisize
  • Propeller Health
  • Proteus Digital Health
  • West Pharmaceutical Services, Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP21524

Global Connected Drug Delivery Devices Market to Reach US$25.5 Billion by 2030

The global market for Connected Drug Delivery Devices estimated at US$7.9 Billion in the year 2024, is expected to reach US$25.5 Billion by 2030, growing at a CAGR of 21.5% over the analysis period 2024-2030. Standalone Components & Software, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$14.8 Billion by the end of the analysis period. Growth in the Integrated Devices segment is estimated at 23.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 20.4% CAGR

The Connected Drug Delivery Devices market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 20.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.3% and 18.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.

Global Connected Drug Delivery Devices Market - Key Trends & Drivers Summarized

What Are Connected Drug Delivery Devices, and Why Are They Transforming Healthcare?

Connected drug delivery devices are medical devices equipped with sensors and connectivity features that allow for the monitoring and management of drug administration. These devices include smart inhalers, insulin pens, wearable injectors, and auto-injectors that transmit real-time usage data to healthcare providers, offering insights into patient adherence and treatment efficacy. Connected drug delivery devices improve medication compliance, provide personalized dosage guidance, and enable remote patient monitoring, making them especially valuable in chronic disease management, where adherence to treatment is crucial for health outcomes. By facilitating seamless communication between patients and healthcare providers, these devices are transforming healthcare delivery, ensuring that patients receive the most effective, personalized care.

The significance of connected drug delivery devices lies in their ability to enhance patient engagement and adherence to prescribed regimens, which is vital in managing chronic conditions like diabetes, asthma, and rheumatoid arthritis. The data collected by these devices offers healthcare providers actionable insights into treatment patterns and patient behavior, enabling proactive intervention when adherence issues arise. Additionally, the real-time feedback provided by connected devices helps patients manage their medications more effectively, reducing the risk of missed doses and potential complications. As healthcare systems increasingly focus on patient-centered, data-driven care, connected drug delivery devices play a crucial role in improving treatment outcomes.

How Are Technological Advancements Enhancing Connected Drug Delivery Devices?

Technological advancements are rapidly improving the capabilities and applications of connected drug delivery devices, making them more precise, patient-friendly, and versatile. Integration of Bluetooth, Wi-Fi, and near-field communication (NFC) technologies allows for seamless data transfer from the device to mobile apps and cloud platforms, where data can be analyzed and accessed by healthcare providers in real time. AI and machine learning algorithms are also transforming connected drug delivery devices, enabling personalized medication schedules and predicting adherence patterns based on patient behavior, enhancing the overall treatment efficacy.

Advances in wearable technology have led to the development of more comfortable and discreet devices, such as smart insulin pumps and wearable injectors, that can deliver medication with minimal disruption to daily life. Furthermore, mobile app integration allows patients to receive reminders, dosage tracking, and educational resources, which promotes adherence and empowers patients to manage their conditions actively. Enhanced battery life and miniaturization have made these devices more portable and user-friendly, catering to the needs of active and mobile patients. Together, these technological advancements make connected drug delivery devices an integral part of modern healthcare, improving patient adherence, convenience, and treatment success.

What Are the Key Applications of Connected Drug Delivery Devices Across Patient Care?

Connected drug delivery devices are widely used across a range of chronic disease management applications, where consistent medication adherence is essential. In diabetes management, smart insulin pens and continuous glucose monitors (CGMs) allow patients to administer and track insulin doses accurately, providing data that supports personalized dosing and reduces the risk of complications. For respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), connected inhalers offer reminders and feedback on inhaler usage, helping patients adhere to prescribed regimens and enabling providers to monitor control of the condition remotely.

In the field of oncology, wearable injectors allow for controlled delivery of chemotherapy drugs, reducing the need for frequent hospital visits and enabling patients to manage their treatment at home. Connected auto-injectors are used in rheumatoid arthritis treatment, ensuring patients receive their medications as prescribed and providing data that healthcare providers can use to optimize treatment plans. In clinical trials, connected drug delivery devices improve data accuracy by capturing precise dosing information, reducing reliance on patient self-reporting and enhancing trial integrity. These applications underscore the versatility of connected drug delivery devices in supporting various aspects of patient care, from disease management to clinical research.

What Factors Are Driving Growth in the Connected Drug Delivery Devices Market?

The growth in the connected drug delivery devices market is driven by several factors, including the rise of chronic diseases, technological advancements in connected healthcare, and increasing emphasis on patient adherence. With the prevalence of chronic conditions like diabetes, asthma, and cardiovascular disease on the rise, connected drug delivery devices are in high demand for their role in improving adherence and ensuring effective treatment outcomes. Technological advancements, such as AI, mobile app integration, and real-time data analytics, are enhancing the capabilities of these devices, making them more user-friendly and effective in managing patient care remotely.

The growing acceptance of telemedicine and remote patient monitoring has further boosted adoption, as connected drug delivery devices allow healthcare providers to track adherence and intervene when necessary, reducing hospital visits and improving patient engagement. Increased focus on personalized medicine has also spurred demand for devices that offer customizable dosing schedules and real-time monitoring, aligning with the trend toward tailored treatment solutions. Moreover, pharmaceutical companies and healthcare providers are recognizing the benefits of connected drug delivery devices in clinical trials, where they improve data accuracy and patient compliance. Together, these factors are driving the expansion of the connected drug delivery devices market, supporting its role in enhancing healthcare delivery and patient outcomes in an increasingly digital healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Connected Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Standalone Components & Software, Integrated Devices); Administration Route (Parenteral Administration, Inhalational Administration); Application (Diabetes Management Application, COPD Application, Asthma Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Adherium Limited
  • Aterica
  • Biocorp
  • FindAir
  • Merck KGaA
  • Phillips Medisize
  • Propeller Health
  • Proteus Digital Health
  • West Pharmaceutical Services, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Connected Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Drives Demand for Connected Drug Delivery Devices That Enable Remote Patient Monitoring
    • Growth in Home Healthcare Expands Market for Connected Drug Delivery Devices That Offer Self-Administration and Real-Time Feedback
    • Rising Focus on Personalized Medicine Propels Demand for Connected Devices That Provide Customizable Dosing and Monitoring
    • Advancements in IoT Technology Strengthen Business Case for Connected Drug Delivery Devices with Real-Time Data Sharing
    • Growing Demand for Patient Adherence Solutions Drives Adoption of Connected Drug Delivery Devices with Reminder and Tracking Features
    • Expansion of Digital Health Solutions Supports Market for Connected Devices That Integrate with Mobile Apps and Health Portals
    • Increasing Focus on Reducing Healthcare Costs Drives Demand for Connected Drug Delivery Devices That Minimize Hospital Visits
    • Rising Use of AI in Healthcare Expands Market for Connected Devices with Predictive Analytics and Personalized Care Features
    • Increasing Need for Continuous Glucose Monitoring Expands Market for Connected Drug Delivery Devices in Diabetes Management
    • Growing Focus on Remote Clinical Trials Drives Demand for Connected Drug Delivery Devices That Enable Real-Time Data Collection
    • Rising Investment in Smart Inhalers and Connected Injectors Propels Growth in Asthma and Respiratory Disease Management
    • Increasing Adoption of Wearable Health Tech Expands Applications of Connected Drug Delivery Devices in Chronic Disease Management
    • Growth in Preventive Healthcare Expands Market for Connected Devices That Monitor Patient Metrics and Predict Health Risks
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Standalone Components & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Standalone Components & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Integrated Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Integrated Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Inhalational Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Inhalational Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Diabetes Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Diabetes Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for COPD Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for COPD Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Asthma Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Connected Drug Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Connected Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • CHINA
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Connected Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030

IV. COMPETITION